Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biochim Biophys Acta ; 1668(2): 234-9, 2005 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-15737334

RESUMEN

hCAT-3 (human cationic amino acid transporter type three) was investigated with both the two-electrode voltage clamp method and tracer experiments. Oocytes expressing hCAT-3 displayed less negative membrane potentials and larger voltage-dependent currents than native or water-injected oocytes did. Ion substitution experiments in hCAT-3-expressing oocytes revealed a large conductance for Na+ and K+. In the presence of L-Arg, voltage-dependent inward and outward currents were observed. At symmetrical (inside/outside) concentrations of L-Arg, the conductance of the transporter increased monoexponentially with the L-Arg concentrations; the calculated Vmax and KM values amounted to 8.3 microS and 0.36 mM, respectively. The time constants of influx and efflux of [3H]L-Arg, at symmetrically inside/outside L-Arg concentrations (1 mM), amounted to 79 and 77 min, respectively. The flux data and electrophysiological experiments suggest that the transport of L-Arg through hCAT-3 is symmetric, when the steady state of L-Arg flux has been reached. It is concluded that hCAT-3 is a passive transport system that conducts monovalent cations including L-Arg. The particular role of hCAT-3 in the diverse tissues remains to be elucidated.


Asunto(s)
Transportador de Aminoácidos Catiónicos 1/metabolismo , Potenciales de la Membrana/fisiología , Oocitos/fisiología , Potasio/metabolismo , Sodio/metabolismo , Animales , Arginina/farmacología , Cationes Monovalentes , Conductividad Eléctrica , Humanos , Potenciales de la Membrana/efectos de los fármacos , Oocitos/efectos de los fármacos , Proteínas Recombinantes/metabolismo , Xenopus laevis
2.
Biochimie ; 91(10): 1335-8, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19393287

RESUMEN

Hepcidin is a 25-residue hepatic peptide that regulates iron absorption from the diet and tissue iron distribution. Inappropriately low Hepcidin expression is implicated in the pathogenesis of hereditary hemochromatosis and iron-loading anemias, like the thalassemias. Increased hepcidin expression mediates iron retention in the anemias of inflammation and plays a pathogenic role in iron-refractory iron-deficiency anemia (IRIDA). Because of its clinical importance, Hepcidin is expected to be a useful biomarker for diagnosis and management of iron-related disorders. So far an ELISA for human hepcidin and SELDI-TOF-MS based approaches have been applied to monitor urinary and/or serum hepcidin levels. Here we report a modified protocol for SELDI-TOF based detection of human, urinary hepcidin. We show that CM10 Proteinchips are superior to NP20 Proteinchips commonly used in previously reported protocols to sensitively and accurately detect urinary hepcidin. Application of this modified hepcidin assay accurately detects increased hepcidin levels in the urine of sepsis patients.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/orina , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Femenino , Hepcidinas , Humanos , Masculino , Reproducibilidad de los Resultados , Sepsis/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA